(Q38219863)
Statements
1 reference
What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer? (English)
1 reference
1 reference
Jaume Capdevila
1 reference
Alfredo Carrato
1 reference
Enrique Grande
1 reference
14 May 2014
1 reference
1 reference
92
1 reference
2
1 reference
83-106
1 reference
Identifiers
1 reference
1 reference